1 – 10 of 28
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Adaptive radiotherapy in locally advanced head and neck cancer : The importance of reduced margins
- Contribution to journal › Article
-
Mark
Investigating the therapeutic potential of FLASH radiotherapy – a treatment planning study
- Contribution to journal › Article
-
Mark
Chemoradiation therapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer-Mature Results of the ARTSCAN III Trial
- Contribution to journal › Article
- 2024
-
Mark
Pre- and Postoperative Antioxidant Use, Aryl Hydrocarbon Receptor (AhR) Activation and Clinical Outcome in Different Treatment Groups of Breast Cancer Patients
- Contribution to journal › Article
-
Mark
Morbiditet från urinvägar och tarm enligt registerdata efter ultrahypofraktionerad strålbehandling för lokaliserad prostatacancer vid 10 år i HYPO-RT-PC-studien
(2024) Onkologidagarna 2024
- Contribution to conference › Poster
-
Mark
Register data on long-term morbidity after prostate cancer radiotherapy with ultra-hypofractionated (2.5 weeks) vs conventional (8 weeks) treatment schedules
(2024) U21 Health Sciences Group 2024 Doctoral Student Forum
- Contribution to conference › Poster
-
Mark
Probably Not!
- Contribution to journal › Letter
-
Mark
Register data on long-term morbidity after prostate ultra-hypofractionation in the HYPO-RT-PC trial
- Contribution to journal › Published meeting abstract
- 2023
-
Mark
Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response
- Contribution to journal › Article
-
Mark
Importance of tumor volume, overall treatment time and fractionation sensitivity for p16-positive and p16-negative oropharyngeal tumors
- Contribution to journal › Article
